The Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery
Disease Models & Mechanisms · 2026
DOI: 10.1242/dmm.052492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Miguel Ramirez-Moreno und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK. Hauptthemen laut MEDLINE: tau Proteins, Wings, Animal, Drosophila melanogaster, Drug Discovery. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Art Libraries Society UK and Ireland, Alzheimer Society of Canada, UBC Centre for Brain Health.
Abstract (Originalsprache)
Tau protein contributes to microtubule stability, which is disrupted in Alzheimer's disease and other Tauopathies. In these diseases, Tau molecules become hyperphosphorylated, misfolded and aggregated, propagating pathology across the brain. Studies dissecting disease mechanisms or screening disease-modifying therapies rely on animal models that unveil pathogenic events in vivo but also take several weeks or months to complete. Here we describe a versatile experimental paradigm that yields results in days and yet offers all the advantages of a genetically tractable in vivo system: the Drosophila wing. Mimicking neurotoxicity, human Tau expression causes cell death in the wing disc leading to quantifiable phenotypes in the adult wing. The neuroprotective peptide NAP ameliorates Tau toxicity in this system, validating it as a cost-effective drug screening tool. Phenocopying adult neurons, Tau toxicity in the wing disc is exacerbated by simulating hyper-phosphorylation and prevented by suppressing aggregation. Additionally, we show that the wing disc can dissect disease mechanisms that underpin clinically relevant Tau variants. Thus, the Drosophila wing offers an in vivo experimental paradigm for fast and efficient exploration of disease mechanism and screening.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK.
- Department of Cellular and Physiological Sciences, Life Science Institute, University of British Columbia, Vancouver V6T 1Z3, Canada.
- Institute for Fundamental Biomedical Research, Biomedical Sciences Research Centre "Alexander Fleming", Vari 16672, Greece.
- School of Biological Sciences, Bangor University, Bangor LL57 2UW, UK.
ORCID-Profile: Miguel Ramirez-Moreno, Amber S Cooper, Seyedehleila Abtahi, Efthimios M C Skoulakis, Lovesha Sivanantharajah, Douglas Watt Allan, Amritpal Mudher
Förderung
- Art Libraries Society UK and Ireland
- Alzheimer Society of Canada
- UBC Centre for Brain Health
- Alzheimer's Society
- Gerald Kerkut Charitable Trust
- Alzheimer Society
- University of British Columbia
- University of Southampton
Zitieren
APA
Ramirez-Moreno, M., Cooper, A. S., Lian, T., Liu, J., Abtahi, S., Skoulakis, E. M. C., Sivanantharajah, L., Allan, D. W., & Mudher, A. (2026). The Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052492
Vancouver
Ramirez-Moreno M, Cooper AS, Lian T, Liu J, Abtahi S, Skoulakis EMC, et al. The Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052492
BibTeX
@article{RamirezMoreno2026,
author = {Ramirez-Moreno, Miguel and Cooper, Amber S and Lian, Tianshun and Liu, Jie and Abtahi, Seyedehleila and Skoulakis, Efthimios M C and Sivanantharajah, Lovesha and Allan, Douglas Watt and Mudher, Amritpal},
title = {The Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery},
journal = {Disease Models & Mechanisms},
year = {2026},
doi = {10.1242/dmm.052492}
}
EUVIMED